We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
37 hedge funds and large institutions have $90.1M invested in scPharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
13% more capital invested
Capital invested by funds: $80M → $90.1M (+$10.1M)
12% more funds holding
Funds holding: 33 → 37 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.22% less ownership
Funds ownership: 58.25% → 58.03% (-0.22%)
43% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 14
Holders
37
Holders Change
+4
Holders Change %
+12.12%
% of All Funds
0.58%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
8
Reduced
14
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
JGC
J. Goldman & Co
New York
|
-$1.49M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$411K |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$163K |
| 4 |
Millennium Management
New York
|
-$42.1K |
| 5 |
Renaissance Technologies
New York
|
-$14.2K |
